癌症预后基因表达、肿瘤微环境与肿瘤浸润免疫细胞的相关性分析。

4区 医学 Q3 Medicine Disease Markers Pub Date : 2023-10-06 eCollection Date: 2023-01-01 DOI:10.1155/2023/9672158
Qing Li, Zongjing Yang, Xingqing Ling, Junming Ye, Jiaying Wu, Yu Wang, Chun Yao, Jinghui Zheng
{"title":"癌症预后基因表达、肿瘤微环境与肿瘤浸润免疫细胞的相关性分析。","authors":"Qing Li,&nbsp;Zongjing Yang,&nbsp;Xingqing Ling,&nbsp;Junming Ye,&nbsp;Jiaying Wu,&nbsp;Yu Wang,&nbsp;Chun Yao,&nbsp;Jinghui Zheng","doi":"10.1155/2023/9672158","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Tumor microenvironment (TME) research can provide a crucial direction for the innovation and continuous improvement of novel biologic therapies for cancer. This study examined the relationship between the TME, expression profiles of the tumor-infiltrating immune cell, and prognostic gene expression in ovarian cancer (OC).</p><p><strong>Materials and methods: </strong>Screening of CD3E, CD3G, CD2, CD3D, CCL19, and IL2RG was performed using the bioinformatics methods.</p><p><strong>Results: </strong>All six genes were found to participate in immune-related molecular mechanisms and could regulate the expression of tumor-infiltrating cells. A Kaplan-Meier survival analysis results demonstrated a strong association between overall survival and all gene expressions in patients with OC. CIBERSORT analysis results showed that the expression level of all genes was positively correlated with <i>γδ</i> T cell proportions.</p><p><strong>Conclusion: </strong>Therefore, in the OC microenvironment, CD3E, CD3G, CD2, CD3D, CCL19, and IL2RG can be potential immunotherapy targets and prognostic markers.</p>","PeriodicalId":11201,"journal":{"name":"Disease Markers","volume":"2023 ","pages":"9672158"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575750/pdf/","citationCount":"0","resultStr":"{\"title\":\"Correlation Analysis of Prognostic Gene Expression, Tumor Microenvironment, and Tumor-Infiltrating Immune Cells in Ovarian Cancer.\",\"authors\":\"Qing Li,&nbsp;Zongjing Yang,&nbsp;Xingqing Ling,&nbsp;Junming Ye,&nbsp;Jiaying Wu,&nbsp;Yu Wang,&nbsp;Chun Yao,&nbsp;Jinghui Zheng\",\"doi\":\"10.1155/2023/9672158\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Tumor microenvironment (TME) research can provide a crucial direction for the innovation and continuous improvement of novel biologic therapies for cancer. This study examined the relationship between the TME, expression profiles of the tumor-infiltrating immune cell, and prognostic gene expression in ovarian cancer (OC).</p><p><strong>Materials and methods: </strong>Screening of CD3E, CD3G, CD2, CD3D, CCL19, and IL2RG was performed using the bioinformatics methods.</p><p><strong>Results: </strong>All six genes were found to participate in immune-related molecular mechanisms and could regulate the expression of tumor-infiltrating cells. A Kaplan-Meier survival analysis results demonstrated a strong association between overall survival and all gene expressions in patients with OC. CIBERSORT analysis results showed that the expression level of all genes was positively correlated with <i>γδ</i> T cell proportions.</p><p><strong>Conclusion: </strong>Therefore, in the OC microenvironment, CD3E, CD3G, CD2, CD3D, CCL19, and IL2RG can be potential immunotherapy targets and prognostic markers.</p>\",\"PeriodicalId\":11201,\"journal\":{\"name\":\"Disease Markers\",\"volume\":\"2023 \",\"pages\":\"9672158\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575750/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Disease Markers\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/2023/9672158\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Disease Markers","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2023/9672158","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的:肿瘤微环境(TME)研究可为癌症新型生物疗法的创新和持续改进提供重要方向。本研究探讨了卵巢癌症(OC)肿瘤浸润免疫细胞TME、表达谱和预后基因表达之间的关系。材料和方法:采用生物信息学方法筛选CD3E、CD3G、CD2、CD3D、CCL19和IL2RG。结果:6个基因均参与免疫相关分子机制,并能调控肿瘤浸润细胞的表达。Kaplan-Meier生存率分析结果表明,OC患者的总生存率与所有基因表达之间存在很强的相关性。CIBERSORT分析结果表明,所有基因的表达水平与γδT细胞比例呈正相关。结论:因此,在OC微环境中,CD3E、CD3G、CD2、CD3D、CCL19和IL2RG可能是潜在的免疫治疗靶点和预后标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Correlation Analysis of Prognostic Gene Expression, Tumor Microenvironment, and Tumor-Infiltrating Immune Cells in Ovarian Cancer.

Objective: Tumor microenvironment (TME) research can provide a crucial direction for the innovation and continuous improvement of novel biologic therapies for cancer. This study examined the relationship between the TME, expression profiles of the tumor-infiltrating immune cell, and prognostic gene expression in ovarian cancer (OC).

Materials and methods: Screening of CD3E, CD3G, CD2, CD3D, CCL19, and IL2RG was performed using the bioinformatics methods.

Results: All six genes were found to participate in immune-related molecular mechanisms and could regulate the expression of tumor-infiltrating cells. A Kaplan-Meier survival analysis results demonstrated a strong association between overall survival and all gene expressions in patients with OC. CIBERSORT analysis results showed that the expression level of all genes was positively correlated with γδ T cell proportions.

Conclusion: Therefore, in the OC microenvironment, CD3E, CD3G, CD2, CD3D, CCL19, and IL2RG can be potential immunotherapy targets and prognostic markers.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Disease Markers
Disease Markers 医学-病理学
自引率
0.00%
发文量
792
审稿时长
6-12 weeks
期刊介绍: Disease Markers is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the identification of disease markers, the elucidation of their role and mechanism, as well as their application in the prognosis, diagnosis and treatment of diseases.
期刊最新文献
Impact of rs599839 Polymorphism on Coronary Artery Disease Risk in Saudi Diabetic Patients. Corrigendum to "Fluvastatin Upregulates the α 1C Subunit of CaV1.2 Channel Expression in Vascular Smooth Muscle Cells via RhoA and ERK/p38 MAPK Pathways". JAK2 as Predictor of Therapeutic Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib Significance of Estrogen/Progesterone Receptor Expression in Metaplastic Breast Carcinoma Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1